These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18973846)

  • 41. [Diagnostic value of five serum markers for liver fibrosis].
    Luo R; Yang S; Xie J; Zhao Z; He Y; Yao J
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnosis of fibrosis and cirrhosis. Liver biopsy is not always necessary.
    Prescrire Int; 2010 Feb; 19(105):38-42. PubMed ID: 20455345
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
    Trocme C; Leroy V; Sturm N; Hilleret MN; Bottari S; Morel F; Zarski JP
    J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores.
    Castéra L; Le Bail B; Roudot-Thoraval F; Bernard PH; Foucher J; Merrouche W; Couzigou P; de Lédinghen V
    J Hepatol; 2009 Jan; 50(1):59-68. PubMed ID: 19013661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of allograft fibrosis by transient elastography and noninvasive biomarker scoring systems in liver transplant patients.
    Beckebaum S; Iacob S; Klein CG; Dechêne A; Varghese J; Baba HA; Sotiropoulos GC; Paul A; Gerken G; Cicinnati VR
    Transplantation; 2010 Apr; 89(8):983-93. PubMed ID: 20335832
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.
    Patel K; Gordon SC; Jacobson I; Hézode C; Oh E; Smith KM; Pawlotsky JM; McHutchison JG
    J Hepatol; 2004 Dec; 41(6):935-42. PubMed ID: 15582126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests.
    Nguyen-Khac E; Chatelain D; Tramier B; Decrombecque C; Robert B; Joly JP; Brevet M; Grignon P; Lion S; Le Page L; Dupas JL
    Aliment Pharmacol Ther; 2008 Nov; 28(10):1188-98. PubMed ID: 18705692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests.
    Calès P; Boursier J; de Lédinghen V; Halfon P; Bacq Y; Leroy V; Dib N; Oberti F; Sawadogo A; Rousselet MC; Lunel F
    Gastroenterol Clin Biol; 2008 Dec; 32(12):1050-60. PubMed ID: 19019606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B].
    Chen YP; Feng XR; Dai L; Ding HB; Zhang L
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):225-7. PubMed ID: 12716522
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02.
    Cacoub P; Carrat F; Bédossa P; Lambert J; Pénaranda G; Perronne C; Pol S; Halfon P
    J Hepatol; 2008 May; 48(5):765-73. PubMed ID: 18314219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-invasive evaluation of liver fibrosis by transient elastography and biochemical markers in elderly inpatients.
    Salles N; Dussarat P; Foucher J; Villars S; de Lédinghen V
    Gastroenterol Clin Biol; 2009 Feb; 33(2):126-32. PubMed ID: 19193508
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
    Zaman A; Rosen HR; Ingram K; Corless CL; Oh E; Smith K
    Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?
    Cheung RC; Currie S; Shen H; Bini EJ; Ho SB; Anand BS; Hu KQ; Wright TL; Morgan TR;
    J Clin Gastroenterol; 2008 Aug; 42(7):827-34. PubMed ID: 18285716
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease.
    Kaneda H; Hashimoto E; Yatsuji S; Tokushige K; Shiratori K
    J Gastroenterol Hepatol; 2006 Sep; 21(9):1459-65. PubMed ID: 16911693
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimization and robustness of blood tests for liver fibrosis and cirrhosis.
    Calès P; Boursier J; Bertrais S; Oberti F; Gallois Y; Fouchard-Hubert I; Dib N; Zarski JP; Rousselet MC;
    Clin Biochem; 2010 Nov; 43(16-17):1315-22. PubMed ID: 20713037
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Serological markers of fibrosis].
    Fernández-Varo G
    Gastroenterol Hepatol; 2012 Dec; 35 Suppl 2():10-6. PubMed ID: 23298654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Non-invasive diagnosis of liver fibrosis: guidelines for the use of biomarkers and FibroScan].
    Vergniol J; de Ledinghen V
    Gastroenterol Clin Biol; 2009 Apr; 33(4):334-44. PubMed ID: 19346090
    [No Abstract]   [Full Text] [Related]  

  • 58. The risks of changing the rules for previously validated biomarkers and using the same patients several times. Response letter to Calès et al. Gastroenterol Clin Biol 2008;32:1050-60: "Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests".
    Munteanu M; Ngo Y; Ratziu V; Poynard T
    Gastroenterol Clin Biol; 2009 May; 33(5):387-8; author reply 388-9. PubMed ID: 19372019
    [No Abstract]   [Full Text] [Related]  

  • 59. Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update.
    Poynard T; Muntenau M; Morra R; Ngo Y; Imbert-Bismut F; Thabut D; Messous D; Massard J; Lebray P; Moussalli J; Benhamou Y; Ratziu V
    Gastroenterol Clin Biol; 2008 Sep; 32(6 Suppl 1):8-21. PubMed ID: 18973843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Introduction].
    Jiménez W
    Gastroenterol Hepatol; 2012 Dec; 35 Suppl 2():1-2. PubMed ID: 23298652
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.